0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

EFFECT OF INTRAVENOUS AND INTRASPINAL TREATMENTS ON CEREBROSPINAL SYPHILIS

GEORGE DRAPER, M.D.
Arch Intern Med (Chic). 1915;XV(1):16-30. doi:10.1001/archinte.1915.00070190019002.
Text Size: A A A
Published online

With the demonstration by Noguchi1 of Spirochaeta pallida in the central nervous system tissues, and with the successful use of salvarsan, paresis and locomotor ataxia have become less matters of purely neurological concern and more problems of infection, immunity and chemotherapy. Under this aspect the syphilitic disturbances of the central nervous system function have taken on a new interest alike for the student of immunity, the clinician and the psychologist. For it is now clear that the symptoms of central nervous system syphilis, be they pain, ataxia, or psychic disturbance, depend, as is the case in acute poliomyelitis, on the location of the damaging lesions.

The therapeutic problem, therefore, is fundamentally of a similar nature to that found in any infection in which the specific agent is sent to destroy the infecting organism. The agent and organism must be brought into contact. The well-known impermeability of the choroid

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();